Search

everythinglearnresearchcommunity

for

Search:↓

New lipid/fiber microplexes improve mRNA therapy for degenerative diseases by enhancing cell function and treatment effectiveness.

New treatments for skin conditions show promise, especially Coacillium® for hair growth in young people with alopecia areata.

2h-ICPR can help screen for insulin antibodies in type 2 diabetes patients.

P-3074 effectively blocks scalp DHT better than oral finasteride.

Dupilumab led to complete hair regrowth and improved skin condition in a young man with severe eczema and hair loss.

ASLAN004 was safe and well-tolerated, supporting further development for treating certain diseases.

Oral contraceptives with cyproterone acetate improved quality of life for women with PCOS more than those with levonorgestrel.

Costunolide may have multiple health benefits, including promoting hair growth and protecting against cancer and diabetes, but more research is needed.

Tofacitinib significantly improved symptoms in a patient with overlapping autoimmune disorders.

Baricitinib was effective in treating a patient with dermatomyositis and hair loss.

Certain compounds, especially those with a propionic substituent, could potentially be new treatments for hair loss and similar disorders.

Upadacitinib may help treat difficult cases of systemic lupus erythematosus.

Immunotherapy with pembrolizumab significantly reduced cancer in a young woman with adrenocortical carcinoma.

Two peptides, RMYYY and VMYMI, may be effective anti-inflammatory drugs.

The combined Myo-inositol and D-chiro-inositol treatment improved weight, hormone levels, and skin conditions in women with PCOS.

Histone H4, released by cells exposed to colchicine, can cause hair loss by inhibiting cell growth and enzyme activity.

iEdgePathDDA effectively finds new drug-disease links, outperforming other methods.

Dexpanthenol may help treat epilepsy and depression.

Mesotherapy with bicalutamide has limited effectiveness for female hair loss.

Potential new drugs for treating PCOS were identified.

Ritlecitinib effectively improves hair regrowth and physician satisfaction in severe alopecia areata over time.

Ritlecitinib helps regrow hair in alopecia areata and is safe for long-term use.

Lichen planopilaris is a rare, chronic condition causing hair loss, mainly in middle-aged women, and early treatment is important to prevent permanent baldness.

A young woman with a rare fungal infection showed significant improvement after treatment with antifungal medication.

LMWP-PDGFA shows promise for improving hair health and treating hair loss with fewer side effects.

Ritlecitinib improved hair regrowth and emotional well-being in some alopecia areata patients.

Baricitinib is a relatively safe and effective treatment for severe alopecia areata.

Scalp cooling therapy helped over 80% of women keep at least half their hair during chemotherapy.

Both types of oral contraceptives improved symptoms and hormone levels in women with PCOS.